Carlos A Fossati

Title: Carlos A. Fossati: Innovator in Chimeric Protein Technology

Introduction

Carlos A. Fossati is a notable inventor based in Argentina, recognized for his contributions to the field of biochemistry and protein engineering. His work primarily focuses on the development of isolated chimeric proteins, which have significant implications in vaccine development and therapeutic applications.

Latest Patents

Carlos A. Fossati holds a patent for "Isolated Chimeric Proteins Of Modified Lumazine Synthase." This invention includes isolated chimeric proteins that consist of up to ten copies of peptides, polypeptides, or protein domains inserted in the amino termini of the Brucella spp. Lumazine synthase enzyme. The patent also covers isolated nucleotide sequences that code for these chimeric proteins, as well as vectors, plasmids, and transformed cells used for expressing the proteins. Additionally, it includes monoclonal and polyclonal antibodies induced by the chimeric proteins, hybridomas producing these antibodies, and various applications such as vaccines and pharmaceutical compounds that incorporate the chimeric proteins, nucleotide sequences, and antibodies.

Career Highlights

Carlos A. Fossati is currently associated with Goldgene LLC, where he continues to advance his research in protein technology. His innovative work has the potential to induce immune responses in higher organisms through the administration of effective vaccines and pharmaceutical compounds. Furthermore, he has explored the use of biosensors that incorporate the chimeric proteins, as well as protein conjugates formed by the chimeric proteins and ligands bound through covalent and noncovalent bonds.

Collaborations

Throughout his career, Carlos has collaborated with esteemed colleagues such as Fernando A. Goldbaum and Diego A. Laplagne. These partnerships have enriched his research and contributed to the advancement of chimeric protein technology.

Conclusion

Carlos A. Fossati is a pioneering inventor whose work in chimeric proteins is paving the way for innovative solutions in medicine and biotechnology. His contributions are significant in the ongoing development of vaccines and therapeutic agents.